{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:20:07Z","timestamp":1792657207909,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1308,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Coffee caffeine consumption (CC) is associated with reduced hepatic fibrosis in patients with chronic liver diseases, such as hepatitis C. The association of CC with nonalcoholic fatty liver disease (NAFLD) has not been established. The aim of this study was to correlate CC with the prevalence and severity of NAFLD. Patients involved in a previously published NAFLD prevalence study, as well as additional NASH patients identified in the Brooke Army Medical Center Hepatology clinic, were queried about their caffeine intake. A validated questionnaire for CC was utilized to assess for a relationship between caffeine and four groups: ultrasound negative (controls), bland steatosis\/not-NASH, NASH stage 0-1, and NASH stage 2-4. A total of 306 patients responded to the CC questionnaire. Average milligrams of total caffeine\/coffee CC per day in controls, bland steatosis\/not-NASH, NASH stage 0-1, and NASH stage 2-4 were 307\/228, 229\/160, 351\/255, and 252\/152, respectively. When comparing patients with bland steatosis\/not-NASH to those with NASH stage 0-1, there was a significant difference in CC between the two groups (<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.005). Additionally, when comparing patients with NASH stage 0-1 to those with NASH stage 2-4, there was a significant difference in coffee CC (<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.016). Spearman's rank correlation analysis further supported a negative relationship between coffee CC and hepatic fibrosis (r = \u22120.215;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.035).<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Coffee CC is associated with a significant reduction in risk of fibrosis among NASH patients. (Hepatology 2012)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.24731","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T16:25:23Z","timestamp":1318263923000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":271,"title":["Association of Coffee and Caffeine Consumption With Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Degree of Hepatic Fibrosis"],"prefix":"10.1097","volume":"55","author":[{"given":"Jeffrey W.","family":"Molloy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20241201","doi-asserted-by":"crossref","first-page":"12481257","DOI":"10.1093\/oxfordjournals.aje.a116433","article-title":"Alcohol, smoking, coffee, and cirrhosis.","volume":"136","author":"Klatsky","year":"1992","journal-title":"Am J Epidemiol"},{"key":"R2-11-20241201","doi-asserted-by":"crossref","first-page":"293297","DOI":"10.1007\/BF00146266","article-title":"Unexpected effects of coffee consumption on liver enzymes.","volume":"9","author":"Casiglia","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"R3-11-20241201","doi-asserted-by":"crossref","first-page":"458465","DOI":"10.1016\/S1047-2797(01)00223-X","article-title":"Coffee, caffeine, and the risk of liver cirrhosis.","volume":"11","author":"Corrao","year":"2001","journal-title":"Ann Epidemiol"},{"key":"R4-11-20241201","doi-asserted-by":"crossref","first-page":"11901195","DOI":"10.1001\/archinte.166.11.1190","article-title":"Coffee, cirrhosis, and transaminase enzymes.","volume":"166","author":"Klatsky","year":"2006","journal-title":"Arch Intern Med"},{"key":"R5-11-20241201","first-page":"202205","article-title":"Does coffee protect against liver cirrhosis?","volume":"12","author":"Gallus","year":"2001","journal-title":"Ann Epidemiol"},{"key":"R6-11-20241201","doi-asserted-by":"crossref","first-page":"419423","DOI":"10.1016\/S1047-2797(02)00462-3","article-title":"Coffee intake and mortality from liver cirrhosis.","volume":"13","author":"Tverdal","year":"2003","journal-title":"Ann Epidemiol"},{"key":"R7-11-20241201","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1053\/j.gastro.2004.09.075","article-title":"Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States.","volume":"128","author":"Ruhl","year":"2005","journal-title":"Gastroenterology"},{"key":"R8-11-20241201","doi-asserted-by":"crossref","first-page":"13601369","DOI":"10.1002\/hep.23162","article-title":"Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.","volume":"50","author":"Freedman","year":"2009","journal-title":"Hepatology"},{"key":"R9-11-20241201","doi-asserted-by":"crossref","first-page":"201209","DOI":"10.1002\/hep.23279","article-title":"Increased coffee consumption is associated with reduced hepatic fibrosis.","volume":"51","author":"Modi","year":"2010","journal-title":"Hepatology"},{"key":"R10-11-20241201","doi-asserted-by":"crossref","first-page":"528534","DOI":"10.1016\/j.jhep.2004.11.039","article-title":"Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case control study.","volume":"42","author":"Gelatti","year":"2005","journal-title":"J Hepatol"},{"key":"R11-11-20241201","doi-asserted-by":"crossref","first-page":"235241","DOI":"10.1001\/jama.2010.518","article-title":"Prevalence and trends in obesity among US adults, 19992008.","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"R12-11-20241201","doi-asserted-by":"crossref","first-page":"13871395","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"R13-11-20241201","doi-asserted-by":"crossref","first-page":"113121","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a populationbased cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R14-11-20241201","doi-asserted-by":"crossref","first-page":"234238","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long term follow up of patients with nonalcoholic fatty liver.","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastro Hepatol"},{"key":"R15-11-20241201","doi-asserted-by":"crossref","first-page":"865873","DOI":"10.1002\/hep.21327","article-title":"Long term follow up of patients with NAFLD and elevated liver enzymes.","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"R16-11-20241201","doi-asserted-by":"crossref","first-page":"595602","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28year followup.","volume":"51","author":"Soderberg","year":"2010","journal-title":"Hepatology"},{"key":"R17-11-20241201","doi-asserted-by":"crossref","first-page":"124131","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis utilizing ultrasound and liver biopsy: a prospective study.","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R18-11-20241201","doi-asserted-by":"crossref","first-page":"24672474","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R19-11-20241201","doi-asserted-by":"crossref","first-page":"282292","DOI":"10.1093\/jnci\/dji039","article-title":"Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer.","volume":"97","author":"Michels","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R21-11-20241201","doi-asserted-by":"crossref","first-page":"16521661","DOI":"10.1002\/hep.23902","article-title":"Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.","volume":"52","author":"Vitaglione","year":"2010","journal-title":"Hepatology"},{"key":"R23-11-20241201","first-page":"2026","article-title":"Efficacy of Vitamin E and Vitamin C in the treatment of nonalcoholic steatohepatitis.","volume":"5","author":"Patel","year":"2010","journal-title":"Pract Gastroenterol"},{"key":"R24-11-20241201","doi-asserted-by":"crossref","first-page":"372384","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLDNASH based on the EASL 2009 special conference.","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"R25-11-20241201","doi-asserted-by":"crossref","first-page":"16751685","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitizone, vitamin E, or placebo for nonalcoholic steatohepatitis.","volume":"362","author":"Sanyal","year":"2010","journal-title":"NEJM"},{"key":"R26-11-20241201","doi-asserted-by":"crossref","first-page":"173178","DOI":"10.1002\/biof.5520130128","article-title":"Antioxidative activities of aroma extracts isolated from natural plants.","volume":"13","author":"Lee","year":"2000","journal-title":"BioFactors"},{"key":"R27-11-20241201","doi-asserted-by":"crossref","first-page":"685694","DOI":"10.1007\/s00204-001-0295-5","article-title":"The coffee components kahweol and cafestol induce gammaglutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat.","volume":"75","author":"Huber","year":"2002","journal-title":"Arch Toxicol"},{"key":"R28-11-20241201","first-page":"535539","article-title":"Elevation of glutathione levels by coffee components and its potential mechanisms.","volume":"500","author":"Scharf","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"R29-11-20241201","doi-asserted-by":"crossref","first-page":"23772384","DOI":"10.1093\/carcin\/17.11.2377","article-title":"Placental glutathione Stransferase (GSTP) induction as a potential mechanism for the anticarcinogenic effect of the coffeespecific components cafestol and kahweol.","volume":"17","author":"Schilter","year":"1996","journal-title":"Carcinogenesis"},{"key":"R30-11-20241201","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1016\/0005-2736(96)00040-5","article-title":"Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species.","volume":"1282","author":"Devasagayam","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"R31-11-20241201","doi-asserted-by":"crossref","first-page":"141154","DOI":"10.1016\/S0009-8981(00)00201-1","article-title":"Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation.","volume":"295","author":"Lee","year":"2000","journal-title":"Clinica Chimica Acta"},{"key":"R32-11-20241201","doi-asserted-by":"crossref","first-page":"16991710","DOI":"10.1053\/j.gastro.2010.06.048","article-title":"Coffee induces expression of glucuronosyltransferases via the aryl hydrocarbon receptor and Nrf2 in liver and stomach.","volume":"139","author":"Kalthoff","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24731","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201202000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T13:49:44Z","timestamp":1741787384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201202000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24731","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14264194.15777351","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}